TY - JOUR
AU - G. Qian
AU - K. Humphreys
AU - J. D. Goldhaber-Fiebert
AU - M. L. Brandeau
A1 - 
AD - Department of Management Science and Engineering, Stanford University, Stanford, CA, USA. Electronic address: gqia189@stanford.edu.; Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, CA, USA; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.; Department of Health Policy, Stanford University, Stanford, CA, USA.; Department of Management Science and Engineering, Stanford University, Stanford, CA, USA.
AN - 38335797
BT - Drug Alcohol Depend
C5 - Opioids & Substance Use; Financing & Sustainability; Healthcare Policy
DA - Mar 1
DO - 10.1016/j.drugalcdep.2024.111112
DP - NLM
ET - 20240201
JF - Drug Alcohol Depend
LA - eng
PY - 2024
SN - 0376-8716 (Print); 0376-8716
SP - 111112
ST - Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis
T1 - Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis
T2 - Drug Alcohol Depend
TI - Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis
U1 - Opioids & Substance Use; Financing & Sustainability; Healthcare Policy
U3 - 10.1016/j.drugalcdep.2024.111112
VL - 256
VO - 0376-8716 (Print); 0376-8716
Y1 - 2024
ER -